Journal: Cancers
Article Title: TOPK Drives IL19-Mediated Crosstalk Between Cancer Cells and Fibroblasts to Promote Solar UV-Induced Skin Damage and Carcinogenesis
doi: 10.3390/cancers17132067
Figure Lengend Snippet: TOPK drives IL19-induced cSCC growth and fibroblast activation. ( A ) Differentially expressed genes in the cytokine–cytokine receptor interaction pathway upon TOPK knockdown. The fold change and p -values of key genes are shown, with IL19 exhibiting the most significant decrease. ( B , C ) Knockdown of TOPK significantly reduced IL19 expression at the protein level and its secretion into the conditioned media (CM) of keratinocytes and cSCC cells, as determined by Western blotting. ( D ) IL19 treatment promoted cSCC A431 and SCC12 cell growth, as assessed by MTS assay. ( E ) cSCC A431 and SCC12 cells were treated with recombinant human IL19 (40 ng/mL) for 4 days. Cell growth was measured using the MTS assay. IL19 treatment significantly increased cell growth compared to untreated controls. ( F ) IL19 activated ERK, PI3K, AKT, and TOPK phosphorylation within 15 to 30 min of treatment, but this effect was not sustained at 24 h, as shown by Western blot analysis. ( G ) IL19 and αSMA expression were elevated in chronic TGFβ-treated BJ-TGFβ fibroblasts compared with normal BJ fibroblasts. ( H – K ) TOPK knockdown significantly suppressed IL19 expression and secretion in both normal BJ fibroblasts and activated BJ-TGFβ fibroblasts. ( L , M ) IL19 treatment enhanced the expression of αSMA and FAPα in normal BJ fibroblasts, as demonstrated by Western blot ( L ) and immunofluorescence staining ( M ). ( N ) The density of αSMA was obtained for each sample. Data are shown as means ± SD from three independent experiments. The asterisks indicate a significant difference compared to the group of control samples ( n = 3) (*, p < 0.05; **, p < 0.01; ***, p < 0.001 and ns: no significant difference, one-way ANOVA followed by Dunnett’s post hoc test).
Article Snippet: Human IL19 protein (10 μg, P7212) was purchased from MedChemExpress (MCE, Princeton, NJ, USA).
Techniques: Activation Assay, Knockdown, Expressing, Western Blot, MTS Assay, Recombinant, Phospho-proteomics, Immunofluorescence, Staining, Control